Apella Capital, LLC Minerva Neurosciences, Inc. Transaction History
Apella Capital, LLC
- $4.28 Billion
- Q3 2025
A detailed history of Apella Capital, LLC transactions in Minerva Neurosciences, Inc. stock. As of the latest transaction made, Apella Capital, LLC holds 39,314 shares of NERV stock, worth $161,187. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,314
Previous 20,939
87.75%
Holding current value
$161,187
Previous $36,000
138.89%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NERV
# of Institutions
22Shares Held
1.98MCall Options Held
0Put Options Held
0-
Federated Hermes, Inc. Pittsburgh, PA1.35MShares$5.54 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA252KShares$1.03 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny117KShares$477,6490.0% of portfolio
-
Geode Capital Management, LLC Boston, MA75.6KShares$310,0620.0% of portfolio
-
Black Rock Inc. New York, NY72.7KShares$297,9420.0% of portfolio
About Minerva Neurosciences, Inc.
- Ticker NERV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,340,190
- Market Cap $21.9M
- Description
- Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of schizophrenia; and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein ...